ROL vs STRO
Rollins Inc (ROL) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Rollins Inc (ROL) is a personal services company listed on NYSE.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported ROL revenue for 2024-12-31 was $3.39B. Net income was $466.4M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
ROL currently screens at market cap $21.73B and trailing P/E 41.4. STRO currently screens at market cap $470.8M.
Not investment advice. Open the ROL and STRO stock pages for the full models.
Not investment advice.